Skip to main content
Equibles
EBRCZ logo

EBRCZ · EBR Systems, Inc.

Track EBRCZ — free

Use EBRCZ with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.22 At close · Sep 1
Rebalance outlook locked
Going-concern doubt — flagged Aug 11, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on the Company's cash, cash equivalents, and marketable securities as of June 30, 2026, and its expectation to generate operating losses and negative operating cash flows in the foreseeable future, as well as potential liquidity to become less than the $2.5 million required under its existing debt covenants during the next twelve months, there exists substantial doubt regarding the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these unaudited condensed consolidated financial statements.”
View the 10-Q filed Aug 11, 2026
Market Cap
$17.92M
Shares
75.34M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.22 Open$0.22 Day$0.22–0.22 52W close$0.19–1.20 Avg vol 30d21K Short int13K · 0.0% float · 2.8d Short vol100% DataNov 2022–Sep 2026 Filing10-Q · Aug 11

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 11, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$6.45M
Trailing 12 months
Net income (TTM)
−$60.76M
Trailing 12 months
Revenue growth YoY
+1,451.2%
Year over year
Operating margin
-2,850.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-415.5%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$44.14M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+24.4%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 2.8 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 16.3 · calm Equity put/call 0.67
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −40%
below
RSI (14) 41
neutral
MACD trend Positive
52-week position 3%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −37%
trailing
YTD return −82%
this year
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of float · ▲ +27.3% MoM · 2.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 38
low risk · 0–100
Fundamentals
Weak
Gross margin 30%
EPS growth +8%
Y/Y
Free cash flow $-56.9M
Balance sheet $36.0M
net debt
Quant / Vol
risk profile
Very High
Volatility 271%
annualized · 1-yr
Max drawdown −84%
past year
ATR 13.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−40% Bearish
RSI (14)
41 Neutral
MACD trend
Positive Bullish
52-week position
3% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of float · ▲ +27.3% MoM · 2.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 3% Range high $1
vs 50-day avg -40%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EBRCZ
EBR Systems, Inc.
this stock
$17.92M -81.5% — — 0.0%
ABT
Abbott Laboratories
 $191.81B -13.1% +5.7% 30.9 1.2%
SYK
Stryker Corp
 $121.41B -9.7% +11.2% 32.8 1.8%
MDT
Medtronic plc
 $117.82B -4.2% +8.4% 24.7 1.1%
BSX
Boston Scientific Corp
 $70.00B -49.6% +12.5% 19.6 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
13.5K
Days to cover
2.8d
Change
+2.9K sh
View
Short Volume
Short vol %
100%
As of
Sep 1, 2026
Short Total
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.6M
Net income (FY)
$-48.8M
EPS diluted
$-0.12
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 24, 2026
This year
14
View
Exempt Offerings
Offering
$25.0M
Filed
Jul 12, 2021
View

Performance

5D 20D 120D MTD YTD
EBRCZ -7.1% -37.5% — -7.5% -81.5%
SPY -0.5% -1.2% +12.6% -0.7% +11.7%
vs SPY -6.6% -36.2% — -6.8% -93.2%
Key facts CIK 1347123 Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)